US 11622991
Protocol for treatment of lupus nephritis
granted A61KA61K31/343A61K31/5377
Quick answer
US patent 11622991 (Protocol for treatment of lupus nephritis) held by AURINIA PHARMACEUTICALS INC. expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AURINIA PHARMACEUTICALS INC.
- Grant date
- Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/343, A61K31/5377, A61K31/573, A61K38/13